MC1568

Catalog #

27761-1

$140 *

Size: 10 mg

Qty

Bulk/Custom

Add to Favorites

*US Pricing only. For international pricing, please contact your local distributor.

●

Purchase

●

Description

Selective inhibitor of class IIa histone deacetylases (HDACs). Exhibits tissue-selective inhibition between members of class II deacetylases in vivo; inhibits HDAC4 and HDAC5 in skeletal muscle and the heart without affecting HDAC3 activity. Displays no inhibition of class I HDAC activity (HDAC1, 2, 3) or expression.

●

Synonyms

MC 1568; MC-1568; (E)-3-[4-[(E)-3-(3-fluorophenyl)-3-oxoprop-1-enyl]-1-methylpyrrol-2-yl]-N-hydroxyprop-2-enamide

●

Product Data Gallery

Product Info

Storage and Usage

Citations

Target(s)

HDAC

Formula

C₁₇H₁₅FN₂O₃

314.3 Da

Solubility

Soluble in DMSO

CAS Registry #

852475-26-4

Background

MC1568, a derivative of (Aryloxopropenyl)pyrrolyl hydroxyamide, is a novel, potent and specific inhibitor of class II histone deacetylase (HDAC), including two subclasses IIa (HDAC4, HDAC5, HDAC6, HDAC7 and HDAC9) and IIb (HDAC6 and HDAC 10), that exhibits strong inhibition against maize class II HDAC with 50% inhibition concentration IC50 value of 22 µM. MC1568 has been found to tissue-selectively inhibits HDAC and arrest myogenesis in cultured muscle cells through three possible mechanisms, including decreasing the expression of myocyte enhancer factor 2D, stabilizing the HDAC3/4 -MEF2D complex and inhibiting the acetylation of differentiation-induced MEF2D. Moreover, MC1568 is able to interfere with RAR- and PPARγ-mediated differentiation-inducing signaling pathways.

References

1. Mai A, et al. J Med Chem. 2005 May 5;48(9):3344-53.
2. Nebbioso A, et al. J Mol Endocrinol. 2010 Oct;45(4):219-28.
3. Nebbioso A, et al. EMBO Rep. 2009 Jul;10(7):776-82.

Skip to the end of the images gallery

Skip to the beginning of the images gallery

MC1568

PRODUCTS

SERVICES

RESOURCES

COMPANY